42 episodes

Official Podcast of the Breast Cancer Research Foundation

Investigating Breast Cancer BCRF

    • Life Sciences
    • 5.0, 47 Ratings

Official Podcast of the Breast Cancer Research Foundation

    The Promise and Potential of Breast Cancer Vaccines with Dr. Karen Anderson

    The Promise and Potential of Breast Cancer Vaccines with Dr. Karen Anderson

    One key goal in developing precision vaccines and immune therapies is to reduce the risk of breast cancer recurrence. Yet currently, there is only one FDA-approved immunotherapy drug for breast cancer, and it benefits just a small subset of women.
    In this episode of Investigating Breast Cancer, we talk with Dr. Karen Anderson about vaccines, harnessing the power of a person’s immune system, and reducing the risk of breast cancer recurrence. And of course, we’d all like to know: What’s the progress? And how has COVID-19 impacted this research?

    • 29 min
    The Underlying Biology of Drug Resistance with Dr. Sarat Chandarlapaty

    The Underlying Biology of Drug Resistance with Dr. Sarat Chandarlapaty

    Advances in cancer therapy have dramatically contributed to the decline in breast cancer deaths over the last three decades. But even with these advances, drug resistance—when tumors stop responding to anti-cancer drugs—remains a serious clinical challenge. Dr. Sarat Chandarlapaty talks about the strategies to prevent cancer cells from evading the drugs designed to kill them. 
    Dr. Chandarlapaty is a laboratory head at the Human Oncology and Pathogenesis Program at the Memorial Sloan Kettering Cancer Center. He's also a BCRF Scientific Advisory Board member and has been a BCRF researcher since 2015.

    • 34 min
    A Cross-disciplinary Approach to Breast Cancer Research with Dr. Antonio Wolff

    A Cross-disciplinary Approach to Breast Cancer Research with Dr. Antonio Wolff

     In the fight to understand and solve breast cancer, “it takes a village.” In this case, the village is more like a globally connected series of research labs, scientists, patients, funders and more. In other words, something that looks a lot like the Translational Breast Cancer Research Consortium (TBCRC). The TBCRC is a collaborative group founded in 2005 to conduct innovative and high-impact clinical trials for breast cancer led by Dr. Antonio Wolff. Dr. Wolff, a BCRF investigator since 2007, is the Chief Operating Officer for the Translational Breast Cancer Research Consortium (TBCRC).

    • 41 min
    Breast Cancer Care and COVID-19: From the Frontlines with Dr. Judy Garber

    Breast Cancer Care and COVID-19: From the Frontlines with Dr. Judy Garber

    Breast cancer—and any cancer—can be incredibly stressful under the best of circumstances for patients, survivors, and their families. In this time of the novel coronavirus (COVID-19), concerns can feel like they’re rising exponentially. So, what do we all need to know? With tons of new information bombarding us at once, what should cancer patients and families consider? Are there practical tactics or is there tangible guidance to stay safe? 
    In this special episode of Investigating Breast Cancer, we talk to Dr. Judy Garber for the answers. Dr. Garber is BCRF’s scientific director and chief of the Division of Cancer Genetics and Prevention at the Dana-Farber Cancer Institute in Boston.

    • 22 min
    Developing Personalized Risk Prediction with Dr. Mark Robson

    Developing Personalized Risk Prediction with Dr. Mark Robson

    Dr. Mark Robson talks about how he’s working to help identify the right tests for the right person at the right age
    How can researchers provide more precise risk estimates so that individuals with inherited risks can make informed decisions about their health, so that the right women are getting the right tests at the right age? Dr. Robson is conducting studies that employ advanced technologies that incorporate information from genetic tests to enhance the precision of genetic risk assessment in women with mutations in the BRCA gene.

    • 29 min
    Unraveling Metastatic Breast Cancer, with Dr. Martine Piccart

    Unraveling Metastatic Breast Cancer, with Dr. Martine Piccart

    Dr. Martine Piccart talks to us about the power of collaboration in metastatic breast cancer research
    Metastasis, the spread of cancer cells from the breast to other sites in the body, is responsible for nearly all breast cancer deaths. Approximately 150,000 men and women are diagnosed with metastatic breast cancer each year. Today, BCRF is the largest private funder of this critical area of research.
    Dr. Martine Piccart is passionate about metastasis research and the vital role that international collaboration plays in her work. A BCRF investigator since 2004, Dr. Piccart’s research aims to better understand the origins of metastatic breast cancer and how it evolves. Through the Breast International Group (BIG), she oversees the AURORA-EU study, the Belgium-based arm of the Evelyn H. Lauder Founder’s Fund for Metastatic Breast Cancer Research. Named for BCRF’s founder, the Founder’s Fund is a multi-year, international collaboration. In 2019, AURORA-EU presented findings on the molecular differences between metastatic cells and other tumor cells, revealing a new avenue of research including the potential for targeted treatments.
    Dr. Piccart is Professor of Oncology at the Université Libre de Bruxelles, Belgium, and Director of Medicine at the Institut Jules Bordet. She is also the co-founder and chair of BIG, which unites 55 academic research groups from around the world, running over 30 trials, and developing numerous research programs.

    • 30 min

Customer Reviews

5.0 out of 5
47 Ratings

47 Ratings

jdale2019 ,

Really Great Podcast on this Topic

Such a great podcast on the topic. Covers a wide range of issues. The doctors are all very knowledgeable and authorities on their subject. Has educated me on many topics related to my personal situation.

StefanieHW ,

Cutting Edge Research Explained by Experts

These outstanding BCRF interview podcasts featuring leaders in the field of breast cancer research have significantly helped me navigate the journey through my 33 yr. old daughter’s diagnosis last year. The insights and knowledge from these podcasts are empowering. Please continue them!!

S. Z. Haque ,

Smart, stimulating & hopeful

A great podcast anyone interested in breast cancer research but also for science nerds. The guests are brilliant and Chris is such a terrific host (I’m very particular about my podcast hosts).

Top Podcasts In Life Sciences

Listeners Also Subscribed To